INGLES MARKETS INC-CLASS A (IMKTA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IMKTA • US4570301048

80.77 USD
+3.33 (+4.3%)
At close: Feb 3, 2026
80.77 USD
0 (0%)
After Hours: 2/3/2026, 8:24:41 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IMKTA. IMKTA was compared to 38 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of IMKTA is average, but there are quite some concerns on its profitability. IMKTA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year IMKTA was profitable.
  • In the past year IMKTA had a positive cash flow from operations.
  • Each year in the past 5 years IMKTA has been profitable.
  • Each year in the past 5 years IMKTA had a positive operating cash flow.
IMKTA Yearly Net Income VS EBIT VS OCF VS FCFIMKTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With a Return On Assets value of 3.26%, IMKTA perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
  • IMKTA's Return On Equity of 5.17% is on the low side compared to the rest of the industry. IMKTA is outperformed by 63.16% of its industry peers.
  • IMKTA has a Return On Invested Capital (3.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.26%
ROE 5.17%
ROIC 3.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMKTA Yearly ROA, ROE, ROICIMKTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With a Profit Margin value of 1.57%, IMKTA perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
  • IMKTA's Profit Margin has declined in the last couple of years.
  • IMKTA has a Operating Margin of 2.16%. This is comparable to the rest of the industry: IMKTA outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of IMKTA has declined.
  • The Gross Margin of IMKTA (23.89%) is comparable to the rest of the industry.
  • IMKTA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.16%
PM (TTM) 1.57%
GM 23.89%
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
IMKTA Yearly Profit, Operating, Gross MarginsIMKTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMKTA is destroying value.
  • IMKTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMKTA Yearly Shares OutstandingIMKTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IMKTA Yearly Total Debt VS Total AssetsIMKTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 4.39 indicates that IMKTA is not in any danger for bankruptcy at the moment.
  • IMKTA has a Altman-Z score (4.39) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of IMKTA is 13.06, which is on the high side as it means it would take IMKTA, 13.06 years of fcf income to pay off all of its debts.
  • IMKTA's Debt to FCF ratio of 13.06 is on the low side compared to the rest of the industry. IMKTA is outperformed by 65.79% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that IMKTA is not too dependend on debt financing.
  • The Debt to Equity ratio of IMKTA (0.31) is better than 65.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 13.06
Altman-Z 4.39
ROIC/WACC0.46
WACC8.44%
IMKTA Yearly LT Debt VS Equity VS FCFIMKTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • IMKTA has a Current Ratio of 3.22. This indicates that IMKTA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.22, IMKTA belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
  • IMKTA has a Quick Ratio of 1.63. This is a normal value and indicates that IMKTA is financially healthy and should not expect problems in meeting its short term obligations.
  • IMKTA has a Quick ratio of 1.63. This is amongst the best in the industry. IMKTA outperforms 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 1.63
IMKTA Yearly Current Assets VS Current LiabilitesIMKTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

  • IMKTA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.76%.
  • Measured over the past years, IMKTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.98% on average per year.
  • IMKTA shows a decrease in Revenue. In the last year, the revenue decreased by -5.42%.
  • IMKTA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.96% yearly.
EPS 1Y (TTM)-20.76%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%1791.25%
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%-2.08%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IMKTA Yearly Revenue VS EstimatesIMKTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
IMKTA Yearly EPS VS EstimatesIMKTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2022 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.36, which indicates a rather expensive current valuation of IMKTA.
  • 68.42% of the companies in the same industry are more expensive than IMKTA, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.18. IMKTA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.36
Fwd PE N/A
IMKTA Price Earnings VS Forward Price EarningsIMKTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMKTA is valued a bit cheaper than 76.32% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IMKTA is valued a bit more expensive than the industry average as 60.53% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 38.74
EV/EBITDA 7.08
IMKTA Per share dataIMKTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.91%, IMKTA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.74, IMKTA pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.91, IMKTA pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

  • The dividend of IMKTA has a limited annual growth rate of 0.12%.
  • IMKTA has paid a dividend for at least 10 years, which is a reliable track record.
  • IMKTA has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years11
IMKTA Yearly Dividends per shareIMKTA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • IMKTA pays out 14.68% of its income as dividend. This is a sustainable payout ratio.
DP14.68%
EPS Next 2YN/A
EPS Next 3YN/A
IMKTA Yearly Income VS Free CF VS DividendIMKTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
IMKTA Dividend Payout.IMKTA Dividend Payout, showing the Payout Ratio.IMKTA Dividend Payout.PayoutRetained Earnings

INGLES MARKETS INC-CLASS A

NASDAQ:IMKTA (2/3/2026, 8:24:41 PM)

After market: 80.77 0 (0%)

80.77

+3.33 (+4.3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)12-16
Earnings (Next)02-05
Inst Owners95.58%
Inst Owner Change-0.6%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.53B
Revenue(TTM)5.33B
Net Income(TTM)83.59M
Analysts84.44
Price TargetN/A
Short Float %7.1%
Short Ratio9.04
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend0.65
Dividend Growth(5Y)0.12%
DP14.68%
Div Incr Years0
Div Non Decr Years11
Ex-Date01-08
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.36
Fwd PE N/A
P/S 0.29
P/FCF 38.74
P/OCF 9.95
P/B 0.95
P/tB 0.95
EV/EBITDA 7.08
EPS(TTM)4.4
EY5.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.09
FCFY2.58%
OCF(TTM)8.11
OCFY10.05%
SpS280.89
BVpS85.09
TBVpS85.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number91.78
Profitability
Industry RankSector Rank
ROA 3.26%
ROE 5.17%
ROCE 5.09%
ROIC 3.86%
ROICexc 4.61%
ROICexgc 4.61%
OM 2.16%
PM (TTM) 1.57%
GM 23.89%
FCFM 0.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.14%
OM growth 5Y-18.48%
PM growth 3Y-31.16%
PM growth 5Y-16.56%
GM growth 3Y-1.42%
GM growth 5Y-1.67%
F-Score6
Asset Turnover2.08
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 13.06
Debt/EBITDA 2.1
Cap/Depr 93.17%
Cap/Sales 2.15%
Interest Coverage 5.78
Cash Conversion 64.72%
Profit Quality 47.37%
Current Ratio 3.22
Quick Ratio 1.63
Altman-Z 4.39
F-Score6
WACC8.44%
ROIC/WACC0.46
Cap/Depr(3y)138.74%
Cap/Depr(5y)127.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.75%
Profit Quality(3y)46.78%
Profit Quality(5y)57.46%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.76%
EPS 3Y-32.58%
EPS 5Y-12.98%
EPS Q2Q%1791.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.42%
Revenue growth 3Y-2.07%
Revenue growth 5Y2.96%
Sales Q2Q%-2.08%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.39%
EBIT growth 3Y-32.56%
EBIT growth 5Y-16.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.35%
FCF growth 3Y-43.53%
FCF growth 5Y-29.5%
OCF growth 1Y-41.3%
OCF growth 3Y-23.15%
OCF growth 5Y-15.14%

INGLES MARKETS INC-CLASS A / IMKTA FAQ

What is the fundamental rating for IMKTA stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMKTA.


What is the valuation status for IMKTA stock?

ChartMill assigns a valuation rating of 2 / 10 to INGLES MARKETS INC-CLASS A (IMKTA). This can be considered as Overvalued.


How profitable is INGLES MARKETS INC-CLASS A (IMKTA) stock?

INGLES MARKETS INC-CLASS A (IMKTA) has a profitability rating of 3 / 10.


What is the valuation of INGLES MARKETS INC-CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INGLES MARKETS INC-CLASS A (IMKTA) is 18.36 and the Price/Book (PB) ratio is 0.95.


How financially healthy is INGLES MARKETS INC-CLASS A?

The financial health rating of INGLES MARKETS INC-CLASS A (IMKTA) is 5 / 10.